{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:41:51Z","timestamp":1777430511154,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.gtc.2009.03.005","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T09:21:48Z","timestamp":1242292908000},"page":"289-303","source":"Crossref","is-referenced-by-count":21,"title":["Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Byron","family":"Cryer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2009.03.005_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2009.03.005_bib3","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial (CREDO)","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gtc.2009.03.005_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gtc.2009.03.005_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.gtc.2009.03.005_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00129784-200505050-00003","article-title":"Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much?","volume":"5","author":"Duffy","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.gtc.2009.03.005_bib7","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0016-5085(99)70545-7","article-title":"Effects of very low doses of daily, long-term aspirin therapy on gastric, duodenal and rectal prostaglandins and on mucosal injury in healthy humans","volume":"117","author":"Cryer","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2009.03.005_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2009.03.005_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/003655200750023705","article-title":"Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers","volume":"35","author":"Fort","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2009.03.005_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2006.02759.x","article-title":"Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drugs","volume":"23","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2009.03.005_bib12","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gtc.2009.03.005_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole for the prevention of recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gtc.2009.03.005_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJMe048330","article-title":"Reducing the risks of gastrointestinal bleeding with antiplatelet therapies","volume":"352","author":"Cryer","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.gtc.2009.03.005_bib15","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1073\/pnas.111150798","article-title":"Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release","volume":"98","author":"Ma","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gtc.2009.03.005_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","article-title":"Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)\/leucovorin (LV) with FU\/LA alone in patients with metastatic colorectal cancer","volume":"21","author":"Kabbinovar","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gtc.2009.03.005_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00004836-200205000-00009","article-title":"Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin\/nonsteroidal antiinflammatory drugs and controls","volume":"34","author":"Sheikh","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2009.03.005_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long-term use of aspirin: meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2009.03.005_bib20","first-page":"A133","article-title":"Long-term incidence of ulcer bleeding with low-dose aspirin after eradication of H pylori: A 4- year prospective cohort study","volume":"128","author":"Chan","year":"2005","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2009.03.005_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.108.190186","article-title":"The impact of prevention on reducing the burden of cardiovascular disease","volume":"118","author":"Kahn","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.gtc.2009.03.005_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"4","author":"Hernandez-Diaz","year":"2006","journal-title":"BMC Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.gtc.2009.03.005_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2009.03.005_bib25","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study","volume":"333","author":"Hallas","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2009.03.005_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.gtc.2009.03.005_bib28","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gtc.2009.03.005_bib29","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin","volume":"103","author":"Yeomans","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.gtc.2009.03.005_bib30","first-page":"402","volume":"29","author":"Lanas","year":"2008","journal-title":"Svedberg on behalf of the ASTERIX Investigators. Risk factors for gastroduodenal ulcer during treatment with acetylsalicylic acid for cardiovascular risk management. European Heart Journal"},{"key":"10.1016\/j.gtc.2009.03.005_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"Lanas","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2009.03.005_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-1-1","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations","volume":"1","author":"de Abajo","year":"2001","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.gtc.2009.03.005_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gtc.2009.03.005_bib35","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","article-title":"Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin","volume":"95","author":"S\u00f8rensen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2009.03.005_bib36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2009.03.005_bib37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.313.7058.652","article-title":"Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials","volume":"313","author":"Collins","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2009.03.005_bib38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/eurheartj\/ehi485","article-title":"Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients","volume":"27","author":"Andreotti","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.gtc.2009.03.005_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2036.2003.01693.x","article-title":"High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease","volume":"18","author":"Ng","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2009.03.005_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cgh.2006.04.019","article-title":"Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications","volume":"4","author":"Lai","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2009.03.005_bib41","first-page":"162","article-title":"Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding","volume":"18","author":"Khurram","year":"2006","journal-title":"J Invasive Cardiol"},{"issue":"18","key":"10.1016\/j.gtc.2009.03.005_bib42","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gtc.2009.03.005_bib43","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2009.03.005_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.2000.00739.x","article-title":"Low-dose misoprostol for the prevention of low-dose aspirin induced gastroduodenal injury","volume":"14","author":"Donnelly","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.gtc.2009.03.005_bib45","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2008.06.021","article-title":"Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study","volume":"6","author":"Watanabe","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2009.03.005_bib46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.clinthera.2004.10.002","article-title":"Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis","volume":"26","author":"Goldstein","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.gtc.2009.03.005_bib47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2009.03.005_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"Lanas","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2009.03.005_bib50","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.14309\/00000434-200809001-00123","article-title":"Omeprazole can prevent the gastroduodenal mucosal injury associated with combined use of clopidogrel and aspirin","volume":"103","author":"Cryer","year":"2008","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2009.03.005_bib51","first-page":"A44","article-title":"Can aspirin be reintroduced with PPI inhibitor INFUSION after endoscopic hemostasis: a double-blinded randomized controlled trial","volume":"130","author":"Sung","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2009.03.005_bib52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0016-5107(02)70402-1","article-title":"Guidelines on the management of anticoagulation and anti-platelet therapy for endoscopic procedures","volume":"55","author":"Eisen","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gtc.2009.03.005_bib53","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.gtc.2009.03.005_bib54","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","author":"Collet","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2009.03.005_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2009.03.005_bib56","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","article-title":"Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities","volume":"32","author":"Li","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.gtc.2009.03.005_bib57","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gtc.2009.03.005_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","article-title":"Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel","volume":"48","author":"Small","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.gtc.2009.03.005_bib59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ahj.2008.09.017","article-title":"Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel","volume":"157","author":"Siller-Matula","year":"2009","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.gtc.2009.03.005_bib60","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2008.05.053","article-title":"Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors","volume":"52","author":"Pezalla","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gtc.2009.03.005_bib61","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1161\/circ.118.suppl_18.S_815","article-title":"Understanding variability in antiplatelet drug effects in acute coronary syndromes. Abstract 3998: proton pump inhibitors effect on clopidogrel effectiveness: the clopidogrel medco outcomes study","volume":"118","author":"Aubert","year":"2008","journal-title":"Circulation"},{"issue":"1303","key":"10.1016\/j.gtc.2009.03.005_bib63","first-page":"1","article-title":"PPI interactions with clopidogrel","volume":"51","year":"2009","journal-title":"The Medical Letter Inc"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855309000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855309000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T11:46:08Z","timestamp":1633434368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855309000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0889855309000326"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2009.03.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}